| pubmed-article:7372404 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7372404 | lifeskim:mentions | umls-concept:C0005261 | lld:lifeskim |
| pubmed-article:7372404 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:7372404 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:7372404 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7372404 | pubmed:dateCreated | 1980-7-28 | lld:pubmed |
| pubmed-article:7372404 | pubmed:abstractText | The solid phase synthesis of alpha-melanocyte stimulating hormone (alpha-MSH) using the benzhydrylamine resin and a number of recently described side chain protecting groups is given. The carboxamide terminal peptide was obtained directly by treatment of the peptide resin with liquid hydrogen fluoride at 0 degrees in the presence of carbonium ion scavengers. The solid phase synthesis of the C-terminal carboxylate hormone, porcine beta-melanocyte stimulating hormone (beta p-MSH), using a 1% cross-linked Merrifield resin and the same side chain protecting groups as in the alpha-MSH synthesis also is presented. Purification of both peptides was carried out by conventional chromatographic techniques. Both hormones were fully active and beta p-MSH was slightly more potent than previously reported in the literature. | lld:pubmed |
| pubmed-article:7372404 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7372404 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7372404 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7372404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7372404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7372404 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7372404 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:7372404 | pubmed:issn | 0367-8377 | lld:pubmed |
| pubmed-article:7372404 | pubmed:author | pubmed-author:HadleyM EME | lld:pubmed |
| pubmed-article:7372404 | pubmed:author | pubmed-author:HrubyV JVJ | lld:pubmed |
| pubmed-article:7372404 | pubmed:author | pubmed-author:YangY CYC | lld:pubmed |
| pubmed-article:7372404 | pubmed:author | pubmed-author:HewardC BCB | lld:pubmed |
| pubmed-article:7372404 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7372404 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:7372404 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7372404 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7372404 | pubmed:pagination | 130-8 | lld:pubmed |
| pubmed-article:7372404 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7372404 | pubmed:meshHeading | pubmed-meshheading:7372404-... | lld:pubmed |
| pubmed-article:7372404 | pubmed:meshHeading | pubmed-meshheading:7372404-... | lld:pubmed |
| pubmed-article:7372404 | pubmed:meshHeading | pubmed-meshheading:7372404-... | lld:pubmed |
| pubmed-article:7372404 | pubmed:meshHeading | pubmed-meshheading:7372404-... | lld:pubmed |
| pubmed-article:7372404 | pubmed:meshHeading | pubmed-meshheading:7372404-... | lld:pubmed |
| pubmed-article:7372404 | pubmed:meshHeading | pubmed-meshheading:7372404-... | lld:pubmed |
| pubmed-article:7372404 | pubmed:meshHeading | pubmed-meshheading:7372404-... | lld:pubmed |
| pubmed-article:7372404 | pubmed:year | 1980 | lld:pubmed |
| pubmed-article:7372404 | pubmed:articleTitle | Synthesis of alpha- and beta-melanocyte stimulating hormones. | lld:pubmed |
| pubmed-article:7372404 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7372404 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:7372404 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7372404 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7372404 | lld:pubmed |
